Brief: FDA Approves Iterum Therapeutics' Orlynvah For Treatment Of Uncomplicated Urinary Tract Infections - Website
25/10/2024 15:53
Oct 25 (Reuters) - FDA:
* FDA APPROVES ITERUM THERAPEUTICS' ORLYNVAH FOR TREATMENT
OF
UNCOMPLICATED URINARY TRACT INFECTIONS - WEBSITE
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity